Published in
Ferrata Storti Foundation, Haematologica, 6(105), p. 1650-1659, 2019
DOI: 10.3324/haematol.2019.222299
Links
Tools
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
Journal article published in 2019 by
Lene Kongsgaard Nielsen,
Claudia Stege 
,
Birgit Lissenberg-Witte,
Bronno van der Holt ,
Ulf-Henrik Mellqvist,
Morten Salomo,
Gerard Bos,
Mark-David Levin,
Heleen Visser-Wisselaar,
Markus Hansson,
Annette van der Velden,
Wendy Deenik,
Juleon Coenen,
Maja Hinge,
Saskia Klein
and other authors.
,
Birgit Lissenberg-Witte,
Bronno van der Holt ,
Ulf-Henrik Mellqvist,
Morten Salomo,
Gerard Bos,
Mark-David Levin,
Heleen Visser-Wisselaar,
Markus Hansson,
Annette van der Velden,
Wendy Deenik,
Juleon Coenen,
Maja Hinge,
Saskia Klein
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 